Pharmacotherapy Grand Rounds for Advent Health

This program has a clinical focus.

UF College of Parmacy students working with an instructor during hospital rounds.

Program Details

  • Intended Audience:  Pharmacists interested associated with the Advent Health Residency Program
  • Universal Activity Number:  0012-0000-22-030-L99-P
  • Contact Hours: 1.0 General hours of ACPE continuing education for pharmacists
  • Program Fees: Complimentary for pharmacists associated with the Advent Health Residency Program
  • Dates Available: 07/01/2022-06/30/2023
  • Activity Type: Knowledge
  • Program Support: No outside financial support was provided.


At the completion of this activity, the participant will be able to:

  • Discuss a novel, controversial, or cutting-edge therapeutic topic used by pharmacists at a tertiary care health system.
  • Review and analyze current literature related to pharmacotherapy and disease state management.
  • Describe pertinent pharmacology and pharmacokinetics of medications utilized in disease state management.
  • Demonstrate narratively how the new pharmacotherapeutic information will be applied to pharmacy practice at a tertiary care health system.

Requirements for Successful Course Completion

Attendance at the RSS Grand Rounds presentation and submit an evaluation within 15 days of the presentation.

Schedule of Activities

TitlePresenterDate and Time
Outpatient Treatment Options for COVID-19Myla NguyenOctober 19, 2022
Treatment options for GIB in LVAD patientsJessica BehnamOctober 25, 2022
Toxicological Emergencies in PediatricsRosie NagyNovember 3, 2022
Management controversies of acute agitation in the EDPatrick FunderburkNovember 8. 2022
Diabetic Kidney DiseaseAmber JohnsonNovember 9, 2022
Updates in HER2 Positive Breast Cancer TreatmentAlexis ErtleNovember 10, 2022
Novel Therapies in ALLAriana TerravecchiaNovember 15, 2022
Controversies in TXA utilizationYeji LeeNovember 29. 2022
Gold 2022 Guideline Updates
Sandy LoukaDecember 16, 2022
GNR Bacteremia ControversiesEmma BallantyneDecember 20, 2022
Submersion injuriesTaylor VandenbergDecember 22, 2022
Use of Direct Oral Anticoagulants in CirrhosisMaha FansaJanuary 3, 2023
Burnout and early departure in clinical pharmacistsGabriella PerezJanuary 10, 2023
beta watch yo self: Beta-lactam induced neurotoxicityOlivia FunkJanuary 12, 2023
CC OBMichelle DillonJanuary 17, 2023
TBDJose Lugo-MartinezJanuary 18, 2023
Glycemic mgmt in the critically/acutely ill patientsJennifer WilsonJanuary 24, 2023
Sleep in the ICUEmily BennettJanuary 31, 2023
Updates of HF Guidelines - Improving GDTM - Utilization of ARNI and SGLT2iKeaton KaplanFebruary 1, 2023
Review of oncologic emergienes (FN, TLS, Hypercalcemia etc)Rebecca FalterFebruary 2, 2023
Phenobarbital for AWSLindsey SelphFebruary 7, 2023
Clostridium difficile Infection - A Review of 2021 Guideline Updates from IDSA and ACGYalda SabaFebruary 8, 2023
Atrial fibrillation in critically ill patientsBrittany AllisonFebruary 9, 2023
2022 Heart Failure Guideline UpdateAlexandra Cruz PabonFebruary 14, 2023
Ocular emergencies- intraocular pressure management/infection/exposuresMaitri PatelFebruary 21, 2023
Antithrombotics in TAVR/TAVIAlexandra CunhaFebruary 23, 2023
Blood pressure managemnt in neuro ICUCaitlyn LawrenceFebruary 28, 2023
ACEI related Angioedema: What options do we haveAshley Guzman MeleroMarch 1, 2023
Review of non-malignant heme type topics (hemophilia, sickle cell, ITP/TTP/HUS, etc) Cheng Ieng WongMarch 2, 2023
Nerve blocks vs systemic medications in the ED- local anesthetics and role of Exparel?Nicholas HammondMarch 7, 2023
Long acting injectables for psychiatric patientsMackenzie WalkerMarch 9, 2023
TBDClintMarch 13, 2023
Biomarkers for the detection and targeted management of rejection after transplantationBrianna NorthMarch 14, 2023
Management of Stenotrophomonas maltophilia infections – should TMP/SMX be considered first lineJackie Espinoza-RamirezMarch 15, 2023
TBDNahla HachmiMarch 22, 2023
TBDRianna ReaApril 3, 2023
Dual therapy for MRSA Bacteremia/endocarditis – is two better than one?Reginald LeandreApril 5, 2023
TBDCarolyn CooleyApril 12, 2023
Alvin TomikaApril 19, 2023
TBDMarquis SmithApril 26, 2023
Serotonin Syndrome Risks, Diagnosis and Management Nhi TranMay 3, 2023
Phenobarbital in AWS, Updating our approach to treatmentChristian CayabyabJune 14, 2023

Disclosure Statement

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

  • Bibidh Subedi, Pharm.D., BCCCP – AdventHealth Orlando, Critical Care Pharmacy Specialist | Medical ICU
  • Myla Nguyen
  • Amber Johnson
  • Keaton Kaplan
  • Jessica Behnam
  • Rosie Nagy
  • Patrick Funderburk
  • Alexis Ertle
  • Ariana Terravecchia
  • Yeji Lee
  • Emma Ballantyne
  • Taylor Vandenberg
  • Maha Fansa
  • Gabriella Perez
  • Olivia Funk
  • Michelle Dillon
  • Jennifer Wilson
  • Emily Bennett
  • Alexandra Cunha
  • Lindsey Selph
  • Brittany Allison
  • Alexandra Cruz Pabon
  • Rebecca Falter
  • Maitri Patel
  • Caitlyn Lawrence
  • Cheng Ieng Wong
  • Nicholas Hammond
  • Mackenzie Walker
  • Clint
  • Brianna North
  • Jackie Espinoza-Ramirez
  • Nahla Hachmi
  • Rianna Rea
  • Carolyn Cooley
  • Alvin Tomika
  • Marquis Smith
  • Christian Cayabyab
  • Jose Lugo-Martinez

Additional Resources

Please review the resources below before registering for the course.


The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.